Non-culprit Vulnerable Plaque
📧 Sign up to get email alerts when something new happens for Non-culprit Vulnerable Plaque.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-10-05Clinical Trial Update: Impact of Evolocumab as an Additional Lipid-lowering Therapy to Changes in Lipid Core Burden Index of Non-culprit Vulnerable Plaque in Patients Who Underwent Percutaneous Coronary Intervention for the Acute Coronary Syndrome [Phase 4]
Phase 4 clinical trial evaluating evolocumab as an added lipid-lowering therapy and its impact on lipid core burden index in non-culprit vul…